balance chronic pain management and responsible opioid...
TRANSCRIPT
Balance
chronic pain management
and responsible opioid
prescribing
Michelle Bardack, M.D.
Family & Community Medicine
April 27, 2011
Opioid – Narcotic Discussion April 27, 2011
• Frame the dilemma
• Federation of State Medical Boards
• Discussion and questions
Overview
2
Opioid – Narcotic Discussion April 27, 2011
United States Statistics
• 70 - 100 million adults have chronic pain1
• 5 -33% of outpatient visits to primary care clinics2
• Unrelieved pain is a public health epidemic
• 2003 JAMA published overall costs to society of $61 billion3, similar to that of cancer and CVD4
3
Opioid – Narcotic Discussion April 27, 2011
It’s the law! 2005 - WHO
“…relief of pain is a basic human right…”5
JCAHO “….Patients have the right to appropriate assessment and management of pain….”6
Pain Relief Act NM January 20, 2003, “….every New Mexican shall receive appropriate treatment for pain,” further, “….health providers have an obligation to treat chronic pain….including the use of controlled substances…”7
4
Opioid – Narcotic Discussion April 27, 2011
• Psychological approach - CBT, Biofeedback, hypnosis
• Injection - TPI, ESI, joint
• Neural blockade - celiac plexus block
• Implants - intrathecal pump, nerve stimulator
• Surgical - cordotomy, neurotomy
• Non-opioid drugs - NSAIDS, acetaminophen
• Adjuvant analgesics - antidepressants, anticonvulsants
• Rehabilitative approaches - hot/cold packs, nerve stim, PT/OT
• CAM - acupuncture, chiropractic, massage
• Lifestyle changes - Etoh, tobacco, sedentary life, wt loss
• Opioids - morphine, oxycodone, fentanyl, methadone
Categories of Pain Treatment
5
Opioid – Narcotic Discussion April 27, 2011
Fear influences us
Last week’s JAMA: Opioid overdose is now the second leading cause of
unintentional death in the USA 8
The 'Oxy Express': Florida's Drug Abuse Epidemic
NPR Morning Edition, March 14, 20119
"If you're a clinic owner or a doctor or an employee knowingly working
at one of these pill mills, we have probably bought dope from you.
And we are probably coming to see you soon.”10
6
Opioid – Narcotic Discussion April 27, 2011
2002 2003 % Change Total drug overdose deaths 253 307 21
Rx drug overdose deaths 66 108 64
Illicit drug overdose deaths 187 199 6
Morphine/heroin 133 (55%) 121 (44%) -9
Cocaine 94 (39%) 110 (40%) 17
Alcohol 76 (31%) 78 (28%) 3
Methadone 28 (11%) 34 (12%) 21
Oxycodone 14 (6%) 26 (9%) 86
Methamphetamine 11 (5%) 21 (8%) 91
Propoxyphene 10 (4%) 18 (6%) 80
Diazepam 12 (5%) 16 (6%) 33
Hydrocodone 18 (7%) 15 (5%) -17
Amitriptyline 8 (3%) 14 (5%) 75
Fentanyl 2 (1%) 8 (3%) 300
Table 1. The Most Common
Drugs Causing Death Among
Total Drug Overdose Deaths in
New Mexico, 2002-2003
Drug Deaths in New Mexico11
7
Opioid – Narcotic Discussion April 27, 2011
DILEMMA
How do we responsibly prescribe opioids and balance management of chronic pain?
Opiophobia12 8
Opioid – Narcotic Discussion April 27, 2011
A New Approach
You will no longer cringe, hide head in
the sand
Rewarding for patient and provider
9
Opioid – Narcotic Discussion April 27, 2011
1. One of the oldest known drugs - opium
2. Appeared in Europe and US in 1800s, — 1890’s 1st Congressional Act--opium taxed — 1914 Harrison Tax Act--criminalized non-clinical
use
3. Where we are today: – Controlled Substances Act 1970’s (CSA) – Schedule classification (Class I - V)
Opioid history
10
Opioid – Narcotic Discussion April 27, 2011
1. Mechanism of action: mu-opioid receptor – Highly variable receptor with a range of responses -
producing wide inter-individual variations
2. Types: short, long, rapid-acting 3. Common side effects
– nausea – sedation – constipation
– pruritus
Pharmacology
11
Opioid – Narcotic Discussion April 27, 2011
An opioid trial is the only way a clinician can determine the efficacy and tolerability of a particular agent in a particular a patient13
Which one to choose?
12
Opioid – Narcotic Discussion April 27, 2011
Patient 14
Doctor14
Regulatory 15
What are barriers to prescribing?
13
Opioid – Narcotic Discussion April 27, 2011
Barriers
Patient barriers • Patient: Fear if adverse affects
• Fear that pain is irreversible and inevitable
• Fear of addiction
• Fear of focusing on symptoms and not cause
14
Opioid – Narcotic Discussion April 27, 2011
Barriers
Doctor barriers = opiophobia – Lack of education about opioids and current
standards
– Fear of toxicity
– Fear of addiction
– Fear of being “scammed or had” by patient
– Fear of regulatory scrutiny
15
Opioid – Narcotic Discussion April 27, 2011
1. States laws restrict Schedule II
– prescription quantity or duration
– prescription validity period
2. Prescription series
3. Triplicates/duplicates
4. Prescription monitoring programs
Regulatory Barriers
16
Opioid – Narcotic Discussion April 27, 2011
Federation of State Medical Boards (FSMB) 2005
Seven Step Process 1. Patient evaluation 2. Treatment plan 3. Informed consent and agreement (contract) 4. Periodic review 5. Consultation 6. Documentation 7. Compliance with controlled substances laws and
regulations
17
Opioid – Narcotic Discussion April 27, 2011
Step 1
Patient evaluation
– Document H & P
– Comorbidities - anxiety, depression, cancer
– History of substance abuse - CAGE, ORT
– Document the indication for opioid use
18
Opioid – Narcotic Discussion April 27, 2011
Step 2
Treatment plan
– Objectives
– Adjust over time
– Don’t forget other modalities
19
Opioid – Narcotic Discussion April 27, 2011
Step 3
Informed consent and agreement contract
– Discuss
– Document
– Contract
– Violation
20
Opioid – Narcotic Discussion April 27, 2011
Step 4
Periodic review
– Evaluate progress toward treatment objective
– FOUR A’s - analgesia, activities, adverse effects, aberrant behaviors16
–Satisfactory response – “Zero pain” vs improved quality of life
21
Opioid – Narcotic Discussion April 27, 2011
Step 5
Consultation
– Be willing to refer patients at risk
• Misuse, abuse, or diversion
• Substance abuse
• Psychiatric disorder
22
Opioid – Narcotic Discussion April 27, 2011
Step 6 - Documentation Accurate and complete medical records
– Treatment objective – Discussion of risks and benefits – Informed consent – Treatments
– Past tried, why failed; Current; Future ideas
– Medications: – Date, type, dosage, and quantity
– Instructions and agreements – Periodic reviews
23
Opioid – Narcotic Discussion April 27, 2011
Step 7
Regulations
– Licensed in the state you are prescribing
– Federal regulations www.usdoj.gov/dea
– State regulations www.nmmb.state.nm.us
https://www.pmp.state.nm.us/pmp/webcenter
24
Opioid – Narcotic Discussion April 27, 2011
Physical Dependence - a state of adaptation that is manifested by drug class-specific signs and symptoms that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug and/or administration of antagonist,
physical dependence, by itself, does not equate with addiction
Vocabulary
25
Opioid – Narcotic Discussion April 27, 2011
Pseudoaddiction - iatrogenic syndrome from the misinterpretation of relief seeking behavior as though they are drug -seeking behaviors that are commonly seen in addiction.
BUT relief of seeking behavior resolves with the institution of effective analgesia
Vocabulary
26
Opioid – Narcotic Discussion April 27, 2011
Substance Abuse - use of a substance for non therapeutic purposes or use of medication for purposes other than those it was prescribed for
Tolerance - a physiologic state resulting from regular use of a drug in which an increased dosage is needed to produce a specific effect or a reduced effect is observed with a constant dose over time.
Tolerance may or may not be evident during opioid treatment and does not equate with addiction.
Vocabulary
27
Opioid – Narcotic Discussion April 27, 2011
Finally Multiple focus areas
for scholarly project/publication
Public
Health
Individual
Health
Public
Policy
Pharmaceutical
Companies
Government
State
National/ International Regulations
28
Opioid – Narcotic Discussion April 27, 2011
2005 National survey on drug use and health www.oas.samhsa.gov
University of Wisconsin – Pain Policy www.painpolicy.wisc.edu
New England Journal of Medicine – Opioid http://www.nejm.org/search?q=opioid+therapy+for+chronic+pain&asug=opio
National Alliance Of Advocates - Buprenorphine Treatment http://www.naabt.org/laws.cfm
Websites
29
Opioid – Narcotic Discussion April 27, 2011
References 1. Gottlieb S. Speech before the American Pain Foundation. Remarks by the Deputy Commissioner for Medical and Scientific Affairs,
Food and Drug Administration to the U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on
Health; December 8, 2005; Washington, DC.
2. Reid MC, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J
Gen Intern Med 2002;17:173-179.
3. Stewart WF, Ricci JA, Chee E, et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA
2003;290:2443-2454.
4. International Association for the Study of Pain and European Federation of IASP Chapters. Unrelieved Pain is a Major Global Health
Care Problem. November 16, 2006. Available at: http://www.iasp-pain.org.
5. World Health Assembly, Cancer Prevention and Control, 58.22 Geneva, Switzerland;
http://www.who.int/medicines/areas/quality_safety/Framework_ACMP_withcover.pdf
6. Joint Commission on Accreditation of Healthcare Organizations pain management Standards Effective January 1, 2001
http://www.jointcommission.org/pain_management/
7. http://www.nmmb.state.nm.us/pdffiles/Rules/NMAC16.10.14_PainManagement.pdf
8. Volkow Nora D. MD et al, Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment, JAMA April 6,
2011 vol.305. No. 13
9. http://www.npr.org/programs/morning-edition/
10. ′Prescription Drug Overdoses: An American Epidemic; http://www.cdc.gov/about/grand-rounds/archives/2011/01-February.htm
11. Shah, Nina MS, NM Epidemiology Report Volume 2004 number 8, October 1, 2004.
12. Forbes, K. Opioids: Beliefs and Myths Journal Pain Palliative Care Pharmacotherapy 2006; 20(3):33-35
13. Opioid Prescribing: Clinical Tools and Risk Management Strategies, Anderson, Alfred V. MD et al, December 31, 2009
14. 4th Edition 2010 Bonica’s Management Of Pain, Chapter 14, Laws And Policies Affecting Pain Management, Aaron M. Gilson
15. Cancer Pain Management Policy Review Group. American Cancer Society Position Statement on Regulatory Barriers to Quality
Cancer Pain Management. National Government Relations Department, American Cancer Society; 2001.
16. Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther. 2000; 17(2);
70-83.
30